These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18982000)
41. Oxygen delivery: implications for the biology and therapy of solid tumors. Rockwell S Oncol Res; 1997; 9(6-7):383-90. PubMed ID: 9406244 [TBL] [Abstract][Full Text] [Related]
43. CpG-island methylation and epigenetic control of resistance to chemotherapy. Teodoridis JM; Strathdee G; Plumb JA; Brown R Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923 [TBL] [Abstract][Full Text] [Related]
44. Cancer therapeutics: Targeting the apoptotic pathway. Khan KH; Blanco-Codesido M; Molife LR Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955 [TBL] [Abstract][Full Text] [Related]
45. [Antimitochondrial agents: a new class of anticancer agents]. André N; Rome A; Carré M; Arch Pediatr; 2006 Jan; 13(1):69-75. PubMed ID: 16298120 [TBL] [Abstract][Full Text] [Related]
46. An outlier theory of cancer curability. Tumor cell differentiation as a therapeutic goal. Seifter EJ; Levitt ML; Kramer BS Am J Med; 1987 Oct; 83(4):757-60. PubMed ID: 3674061 [TBL] [Abstract][Full Text] [Related]
47. Opportunities and challenges in combination gene cancer therapy. Nastiuk KL; Krolewski JJ Adv Drug Deliv Rev; 2016 Mar; 98():35-40. PubMed ID: 26724249 [TBL] [Abstract][Full Text] [Related]
48. A mathematical model of chromosome recombination-induced drug resistance in cancer therapy. Yang HL; Lei JZ Math Biosci Eng; 2019 Aug; 16(6):7098-7111. PubMed ID: 31698605 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapeutic failure: resistance or insensitivity? Braverman AS Ann Intern Med; 1993 Apr; 118(8):630-2. PubMed ID: 8452329 [TBL] [Abstract][Full Text] [Related]
50. Glutathione based approaches to improving cancer treatment. Kauvar LM; Morgan AS; Sanderson PE; Henner WD Chem Biol Interact; 1998 Apr; 111-112():225-38. PubMed ID: 9679557 [TBL] [Abstract][Full Text] [Related]
51. Resistance to cytotoxic agents. Robert J Curr Opin Pharmacol; 2001 Aug; 1(4):353-7. PubMed ID: 11710732 [TBL] [Abstract][Full Text] [Related]
52. [Perspectives of improvement of chemotherapy effectiveness in disseminated solid tumors]. Sivashinskiĭ MS Vopr Onkol; 2004; 50(2):237-42. PubMed ID: 15176230 [No Abstract] [Full Text] [Related]
53. Drug independence and the curability of cancer by combination chemotherapy. Pomeroy AE; Schmidt EV; Sorger PK; Palmer AC Trends Cancer; 2022 Nov; 8(11):915-929. PubMed ID: 35842290 [TBL] [Abstract][Full Text] [Related]
54. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Crawford S Front Pharmacol; 2013; 4():68. PubMed ID: 23805101 [TBL] [Abstract][Full Text] [Related]
55. Why some tumors fail to respond to chemotherapy. Comments on a new model of drug sensitivity and resistance. Hansson J Acta Oncol; 1998; 37(7-8):627-8. PubMed ID: 10050978 [No Abstract] [Full Text] [Related]
57. Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis. Savage P BMC Cancer; 2016 Nov; 16(1):906. PubMed ID: 27871274 [TBL] [Abstract][Full Text] [Related]
58. Why does cytotoxic chemotherapy cure only some cancers? Savage P; Stebbing J; Bower M; Crook T Nat Clin Pract Oncol; 2009 Jan; 6(1):43-52. PubMed ID: 18982000 [TBL] [Abstract][Full Text] [Related]